NCT04778514View on ClinicalTrials.gov

A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

September 11, 2023

Study Completion Date

September 11, 2023

Conditions
HIV InfectionsContraception
Interventions
DRUG

Dual Prevention Pill

a single over-encapsulated DPP containing a PrEP tablet and a COC

DRUG

PrEP and combined oral contraceptive (COC) as two separate tablets

PrEP tablet and a COC as two separate tablets

Trial Locations (1)

Unknown

University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC), Belgravia

All Listed Sponsors
collaborator

University of Zimbabwe

OTHER

lead

Population Council

OTHER